维普期刊资源整合服务平台（V6.5）

366篇 您的检索式：作者名="SONNEVELD P"

选中清除导出查看参考文献查看引证文献引用追踪共19页首页上一页第1页下一页末页 /19 跳转

	题名	作者	年代	出处	被引量
1	Bortezomib or high-dose dexamethasone for relapsed multiple myeloma显示文摘	Richardson PG Sonneveld P Schuster MW		0，，：	2
2	Bortezomib or high-dose dexamethasone for relapsed multiple myeloma显示文摘	RICHARDSON P G SONNEVELD P SCHUSTER M W	2005	N Engl J Med2005，352，24：	1
3	The p rog-nostic significance of membrane transport2associated multidrug resistance (MDR) proteins in leukenia 显示文摘	Van der Heuvel-EibrinkM M Sonneveld P Pieters R	2000	Int J Clin Pharmacol Ther2000，38，3：	1
4	Bortezomib or high-dose dexamethasone for relapsed multiple myeloma显示文摘	RICHARDSON PG SONNEVELD P SCHUSTER MW	2005	N Engl J Med2005，352，24：	1
5	RandomizedphaselII study of pegylated liposo- real doxorubiein plusbortezomib compared with bortezomib alone in relapsedor refrac- tory multiple mye\|oma:eombination therapyimproves time to progression显示文摘	Orlowski RT_agler A Sonneveld P	2007	CIinOneol2007，25，：	1
6	Multidrug resistance in haematological malignancies显示文摘	Sonneveld P	2000	J Intern Med2000，247，5：	1
7	Reversal of drug resistance by cycliosporine A in a patient with acute myelocyitic leukemia显示文摘	Sonneveld P Nooter K	1990	Br J Haematol1990，75，：	1
8	High expression of the multidrug resistance- associated protein(MRP)in chronic and prolymphocytic leukemia显示文摘	Burger H Nooter K Sonneveld P	1994	British Journal of haematology1994，88，：	1
9	HOVON- 65/GMMG-HD4 randomized phase III trial comparing borte-zomib, doxorubicin, dexamethasone (PAD) vs VAD followed by high close melphalan and maintenance with bortezomib ortha- lidomide in patients with newly diagnosed multiple myeloma 显示文摘	Sonneveld P Schmidt-Wolfl G vander Holt B	2010	Blood2010，116，：	1
10	Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase Ⅲ APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline显示文摘	Richardson PG Sonneveld P Schuster MW	2009	Br J Haematol2009，144，6：	1
11	Chemotherapy resistance in acute myeloid leukaemia显示文摘	Sonneveld P List AF		0，，：	1
12	Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma显示文摘	Richardson PG Sonneveld P Schuster MW	2007	Br J Haematol2007，137，5：	1
13	Extended follow-up of a phase 3 trial in relapsed multiple myeloma:final time-to-event results of the APEX trial显示文摘	Richardson PG Sonneveld P Schuster M		0，，：	1
14	Active packaging tech- nologies with an emphasis on antimicrobial packaging and its application显示文摘	Suppakul P Miltz J Sonneveld K	2003	Journal of Food Science2003，68，2：	1
15	Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial显示文摘	Richardson PG Sonneveld P SchusterM	2007	Blood2007，110，10：	1
16	Three-demensional landscape process modeling: the effect of DEM resolution 显示文摘	SCHOORL J M SONNEVELD M P W VELDKAMP A	2000	Earth Surface Processes and Landforms2000，25，：	1
17	Nieuwe kasbedekkingsmaterialen besparen en- gergie显示文摘	Sonneveld P	1999	Groente en Fruit1999，99，42：	1
18	Bortezomib or high-dose dexamethasone for relapsed multiple myeloma显示文摘	RICHARDSON PG SONNEVELD P SCHUSTER MW		0，，24：	1
19	Bortezomib induc- tion and maintenance treatment in patients with newly diagnosed multi- ple myeloma: results of the randomized phase III HOVON-65/GMMG- HIM trial显示文摘	Sonneveld P Schmidt-Wolf IG van der Holt B	2012	J Clin 0ncol2012，30，24：	1
20	Bortezomib induc- tion and maintenance treatment in patients with newly diagnosed multiple myeloma:results of the randomized phase I HOVON-65/GMMG-HD4 trial显示文摘	Sonneveld P Sehmidt-Wolf IG Van Der Holt B	2012	J Clin Oncol2012，30，24：	1

返回顶部每页显示：

共19页首页上一页第1页下一页末页 /19 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示